Forgot what you're looking for? Bad with names? Writing down a lot of lists but then misplacing them? Like most people, you're experiencing some memory loss—and growing older doesn't help matters. Luckily, researchers all over the world are scouring the earth looking for ingredients that might organically improve human recall.
What does it mean to be brave? If you ask your child this question, your child will probably say that being brave means not being afraid. That’s the wrong answer. It’s also an answer that keeps kids from becoming brave.
Summer is coming to an end and that means back-to-school time. Along with the backpacks and school supplies, equip your family with natural remedies that will keep your children healthy throughout the school year.
Phase 2 Trial Recruiting Scleroderma Patients with Pulmonary Arterial Hypertension (PAH) in Test of Rituxan
A clinical trial exploring if Rituxan (rituximab) is effective in
managing pulmonary arterial hypertension (PAH) in patients with scleroderma is now recruiting participants in numerous locations across the U.S.
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.